The seroprevalence of HAV IgG among Korean plasmapheresis donors is lowest in those aged 30-40s, suggesting this group should be prioritized for HAV vaccination to prevent transfusion-transmitted infections during outbreaks.
JungWon Kang, M.S., Ji Yeong Seon, M.T., Deuk Yeong Ko, M.S., Taeeun Kim M.S., Jaehyun Kim, Ph.D., Nam-Sun Cho, M.D., Kyoung Young Choi, M.S.. KJBT 2025;36:134-42. https://doi.org/10.17945/kjbt.2025.36.3.134
Kang et al. (Tue,) studied this question.